Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally widespread chronic liver condition that may progress to severe liver diseases, including advanced liver fibrosis. The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol (hs-CRP/HDL-C) ind...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Liang, Xue Qiu, Jiansheng Huang, Yequan Lu, Hairong Shen, Jianchao Ma, Yongyu Chen
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88685-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862328254267392
author Bin Liang
Xue Qiu
Jiansheng Huang
Yequan Lu
Hairong Shen
Jianchao Ma
Yongyu Chen
author_facet Bin Liang
Xue Qiu
Jiansheng Huang
Yequan Lu
Hairong Shen
Jianchao Ma
Yongyu Chen
author_sort Bin Liang
collection DOAJ
description Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally widespread chronic liver condition that may progress to severe liver diseases, including advanced liver fibrosis. The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol (hs-CRP/HDL-C) index may be a potential indicator for MASLD and advanced liver fibrosis, given its relevance to inflammation and plasma lipids. In this study, the hs-CRP/HDL-C index was investigated in relation to prevalent MASLD and advanced liver fibrosis. The study analyzed secondary data from the National Health and Nutrition Examination Survey (NHANES) 2017–2018 database. The hs-CRP/HDL-C index was calculated by the quotient of hs-CRP and HDL-C. Multiple logistic regression models, Cochran-Armitage trend tests, smooth curve fitting, threshold effect analyses, and stratified analyses were used to evaluate whether the hs-CRP/HDL-C index associated with MASLD and advanced liver fibrosis. The study cohort comprised 3684 participants, of whom 1268 (34.42%) were diagnosed with MASLD and 156 (12.28%) with advanced liver fibrosis. Logistic analyses adjusted for covariates revealed positive associations of the hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, consistent across all subgroups. Smooth curve fitting and threshold effect analyses revealed nonlinear relationships of hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, with inflection points at 0.8 for MASLD and 1.2 for advanced liver fibrosis. Additionally, significant interactions were observed between MASLD and covariates such as gender, smoking status, chronic kidney disease (CKD), and cancer. Similarly, the hs-CRP/HDL-C index exhibited positive correlations with advanced liver fibrosis across diverse subgroups, with notable interactions related to cancer. MASLD and advanced liver fibrosis were associated with hs-CRP/HDL-C index, indicating its potential utility as a clinical marker for these conditions.
format Article
id doaj-art-a9e463d6e5474465ac9eb9c65fd061f5
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a9e463d6e5474465ac9eb9c65fd061f52025-02-09T12:35:45ZengNature PortfolioScientific Reports2045-23222025-02-0115111010.1038/s41598-025-88685-yNonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018Bin Liang0Xue Qiu1Jiansheng Huang2Yequan Lu3Hairong Shen4Jianchao Ma5Yongyu Chen6Department of Gastroenterology, Minzu Hospital of Guangxi Medical UniversityDepartment of Cardiology, The first Affiliated Hospital of Guangxi Medical UniversityDepartment of Cardiology, The first Affiliated Hospital of Guangxi Medical UniversityDepartment of Respiratory, Nanxishan Hospital of Guangxi Zhuang Autonomous RegionDepartment of Spleen and Gastrointestinal Endocrinology, Shenzhen Pingle Orthopedic Hospital, Pingshan District Traditional Chinese Medical Hospital)Department of Orthopedics, Minzu Hospital of Guangxi Medical UniversityDepartment of Hematology, Minzu Hospital of Guangxi Medical UniversityAbstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally widespread chronic liver condition that may progress to severe liver diseases, including advanced liver fibrosis. The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol (hs-CRP/HDL-C) index may be a potential indicator for MASLD and advanced liver fibrosis, given its relevance to inflammation and plasma lipids. In this study, the hs-CRP/HDL-C index was investigated in relation to prevalent MASLD and advanced liver fibrosis. The study analyzed secondary data from the National Health and Nutrition Examination Survey (NHANES) 2017–2018 database. The hs-CRP/HDL-C index was calculated by the quotient of hs-CRP and HDL-C. Multiple logistic regression models, Cochran-Armitage trend tests, smooth curve fitting, threshold effect analyses, and stratified analyses were used to evaluate whether the hs-CRP/HDL-C index associated with MASLD and advanced liver fibrosis. The study cohort comprised 3684 participants, of whom 1268 (34.42%) were diagnosed with MASLD and 156 (12.28%) with advanced liver fibrosis. Logistic analyses adjusted for covariates revealed positive associations of the hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, consistent across all subgroups. Smooth curve fitting and threshold effect analyses revealed nonlinear relationships of hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, with inflection points at 0.8 for MASLD and 1.2 for advanced liver fibrosis. Additionally, significant interactions were observed between MASLD and covariates such as gender, smoking status, chronic kidney disease (CKD), and cancer. Similarly, the hs-CRP/HDL-C index exhibited positive correlations with advanced liver fibrosis across diverse subgroups, with notable interactions related to cancer. MASLD and advanced liver fibrosis were associated with hs-CRP/HDL-C index, indicating its potential utility as a clinical marker for these conditions.https://doi.org/10.1038/s41598-025-88685-yHigh-sensitivity C-reactive proteinHigh-density lipoprotein cholesterolMetabolic dysfunction-associated steatotic liver diseaseAdvanced liver fibrosisNHANES
spellingShingle Bin Liang
Xue Qiu
Jiansheng Huang
Yequan Lu
Hairong Shen
Jianchao Ma
Yongyu Chen
Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
Scientific Reports
High-sensitivity C-reactive protein
High-density lipoprotein cholesterol
Metabolic dysfunction-associated steatotic liver disease
Advanced liver fibrosis
NHANES
title Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
title_full Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
title_fullStr Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
title_full_unstemmed Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
title_short Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
title_sort nonlinear associations of the hs crp hdl c index with metabolic dysfunction associated steatotic liver disease and advanced liver fibrosis in us adults insights from nhanes 2017 2018
topic High-sensitivity C-reactive protein
High-density lipoprotein cholesterol
Metabolic dysfunction-associated steatotic liver disease
Advanced liver fibrosis
NHANES
url https://doi.org/10.1038/s41598-025-88685-y
work_keys_str_mv AT binliang nonlinearassociationsofthehscrphdlcindexwithmetabolicdysfunctionassociatedsteatoticliverdiseaseandadvancedliverfibrosisinusadultsinsightsfromnhanes20172018
AT xueqiu nonlinearassociationsofthehscrphdlcindexwithmetabolicdysfunctionassociatedsteatoticliverdiseaseandadvancedliverfibrosisinusadultsinsightsfromnhanes20172018
AT jianshenghuang nonlinearassociationsofthehscrphdlcindexwithmetabolicdysfunctionassociatedsteatoticliverdiseaseandadvancedliverfibrosisinusadultsinsightsfromnhanes20172018
AT yequanlu nonlinearassociationsofthehscrphdlcindexwithmetabolicdysfunctionassociatedsteatoticliverdiseaseandadvancedliverfibrosisinusadultsinsightsfromnhanes20172018
AT hairongshen nonlinearassociationsofthehscrphdlcindexwithmetabolicdysfunctionassociatedsteatoticliverdiseaseandadvancedliverfibrosisinusadultsinsightsfromnhanes20172018
AT jianchaoma nonlinearassociationsofthehscrphdlcindexwithmetabolicdysfunctionassociatedsteatoticliverdiseaseandadvancedliverfibrosisinusadultsinsightsfromnhanes20172018
AT yongyuchen nonlinearassociationsofthehscrphdlcindexwithmetabolicdysfunctionassociatedsteatoticliverdiseaseandadvancedliverfibrosisinusadultsinsightsfromnhanes20172018